Sub-Sensitivity to Long-Acting Bronchodilators (LABA).
Phase of Trial: Phase II
Latest Information Update: 03 Apr 2017
At a glance
- Drugs Budesonide/formoterol (Primary) ; Salmeterol/fluticasone propionate (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 19 Jul 2011 Planned end date changed from 1 Jun 2011 to 1 Dec 2011 as reported by ClinicalTrials.gov.
- 08 May 2010 New trial record